Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 019520

Expand all

TRAVASOL 2.75% IN DEXTROSE 10% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
2.75%;10GM/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: TRAVASOL 2.75% IN DEXTROSE 10% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.75%;10GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019520
Product Number: 002
Approval Date: Sep 23, 1988
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 2.75% IN DEXTROSE 15% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
2.75%;15GM/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: TRAVASOL 2.75% IN DEXTROSE 15% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.75%;15GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019520
Product Number: 003
Approval Date: Sep 23, 1988
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 2.75% IN DEXTROSE 20% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
2.75%;20GM/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: TRAVASOL 2.75% IN DEXTROSE 20% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.75%;20GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019520
Product Number: 004
Approval Date: Sep 23, 1988
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 2.75% IN DEXTROSE 25% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
2.75%;25GM/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: TRAVASOL 2.75% IN DEXTROSE 25% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.75%;25GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019520
Product Number: 005
Approval Date: Sep 23, 1988
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 2.75% IN DEXTROSE 5% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
2.75%;5GM/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: TRAVASOL 2.75% IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.75%;5GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019520
Product Number: 001
Approval Date: Sep 23, 1988
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
4.25%;10GM/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;10GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019520
Product Number: 007
Approval Date: Sep 23, 1988
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 4.25% IN DEXTROSE 15% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
4.25%;15GM/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: TRAVASOL 4.25% IN DEXTROSE 15% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;15GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019520
Product Number: 008
Approval Date: Sep 23, 1988
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
4.25%;20GM/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;20GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019520
Product Number: 009
Approval Date: Sep 23, 1988
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
4.25%;25GM/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: TRAVASOL 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;25GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019520
Product Number: 010
Approval Date: Sep 23, 1988
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
4.25%;5GM/100ML
Marketing Status: Discontinued

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;5GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019520
Product Number: 006
Approval Date: Sep 23, 1988
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information